Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
350 studies found for:    Open Studies | "Prednisone"
Show Display Options
Rank Status Study
21 Recruiting Study of Carfilzomib Weekly Plus Melphalan and Prednisone in Untreated Symptomatic Elderly Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Carfilzomib
22 Recruiting Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: docetaxel;   Drug: pasireotide;   Drug: prednisone
23 Not yet recruiting The Effect of Prednisone and Solu-Medrol on Physical Exercise in COPD Patients and Inflammatory Response During and After Exercise
Condition: Exercise Performance in Copd Patients
Intervention: Drug: prednisone
24 Recruiting Preventing Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone
Condition: HIV Associated Tuberculosis
Interventions: Drug: Prednisone;   Drug: Placebo
25 Recruiting Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: Prednisone;   Drug: Deflazacort
26 Recruiting Phase 3 Study of Carfilzomib, Melphalan, Prednisone vs Bortezomib, Melphalan, Prednisone in Newly Diagnosed Multiple Myeloma (CLARION)
Condition: Multiple Myeloma
Interventions: Drug: Carfilzomib;   Drug: Bortezomib;   Drug: Melphalan;   Drug: Prednisone
27 Unknown  Methotrexate as a Steroid-sparing Agent in Idiopathic Retroperitoneal Fibrosis: a Randomised, Multicenter Trial
Conditions: Idiopathic Retroperitoneal Fibrosis;   Perianeurysmal Retroperitoneal Fibrosis;   Chronic Periaortitis
Interventions: Drug: Methotrexate+Prednisone;   Drug: Prednisone
28 Recruiting Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Metastatic Castration Resistant Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Docetaxel, Reolysin and Prednisone;   Drug: Docetaxel and Prednisone
29 Recruiting Long-term Prednisone Use for End-stage Heart Failure
Conditions: Heart Failure;   Hyperuricemia
Intervention: Drug: prednisone
30 Not yet recruiting Trial of Abiraterone Acetate Plus LHRH-therapy Versus Abiraterone Acetate Sparing LHRH-therapy in Patients With Progressive Chemotherapy-naïve Castration-resistant Prostate Cancer (SPARE)
Condition: Prostate Cancer
Interventions: Drug: abiraterone acetate + prednisone + LHRH-therapy;   Drug: abiraterone acetate + prednisone
31 Not yet recruiting Rituximab and Belimumab for Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Rituximab;   Drug: Cyclophosphamide;   Drug: Prednisone;   Drug: Methylprednisolone;   Drug: Diphenhydramine;   Drug: Acetaminophen;   Biological: Belimumab
32 Not yet recruiting A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Velcade;   Drug: Melphalan;   Drug: Prednisone;   Drug: Daratumumab
33 Recruiting A Randomized Double-Blind Controlled Trial of Single Oral Dose Dexamethasone Versus Five Days of Oral Prednisone in Acute Mild to Moderate Adult Asthma
Conditions: Asthma;   Reactive Airway Disease
Interventions: Drug: Dexamethasone;   Drug: Prednisone
34 Recruiting Enzalutamide With or Without Abiraterone Acetate and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: enzalutamide;   Drug: abiraterone;   Drug: prednisone
35 Recruiting A Study of Oprozomib, Melphalan, and Prednisone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Oprozomib;   Drug: Melphalan;   Drug: Prednisone
36 Not yet recruiting Weekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to 27 mg/m2 Carfilzomib
Condition: Multiple Myeloma
Interventions: Drug: Carfilzomib;   Drug: Dexamethasone;   Drug: Prednisone;   Drug: Methylprednisolone
37 Recruiting Chronic Rhinosinusitis With or Without Nasal Polyps Steroid Study
Conditions: Chronic Sinusitis;   Rhinosinusitis;   Nasal Polyps
Intervention: Drug: Prednisone
38 Recruiting Prednisone for Heart Failure Patients With Hyperuricemia
Condition: Heart Failure, Hyperuricemia
Interventions: Drug: Prednisone;   Drug: Allopurinol
39 Not yet recruiting Low Dose Steroids in the Treatment of Nephrotic Syndrome Relapse
Condition: Glomerular Disease
Interventions: Drug: prednisone 60 mg/meter square Body Surface Area;   Drug: prednisone 45 mg;   Drug: prednisone 30 mg
40 Recruiting Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma Patients
Condition: Multiple Myeloma
Interventions: Drug: Melphalan;   Drug: Prednisone;   Drug: Cyclophosphamide;   Drug: Dexamethasone;   Dietary Supplement: Ascorbic acid;   Drug: PLD;   Drug: Lenalidomide

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years